Centerline Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
+172
New +$176K 0.06% 79
2026
Q1
Sell
-699
Closed -$751K 76
2025
Q4
$751K Sell
699
-265
-27% -$253K 0.27% 39
2025
Q3
$736K Buy
964
+49
+5% +$36.5K 0.32% 29
2025
Q2
$713K Sell
915
-4
-0.4% -$3.11K 0.35% 28
2025
Q1
$759K Sell
919
-28
-3% -$23.3K 0.45% 22
2024
Q4
$731K Buy
+947
New +$784K 0.43% 22

Other funds holding LLY

Centerline Wealth Advisors's LLY Position: Q2 2026 in Review

Centerline Wealth Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 172 shares worth $206K. The stake represents 0.06% of the portfolio and ranks #79 among its holdings. This is a return to the name: Centerline Wealth Advisors previously reported a position in LLY as recently as Q4 2025.

Centerline Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $759K in Q1 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Centerline Wealth Advisors held 172 shares of Eli Lilly worth $206K as of Q2 2026.
  • Eli Lilly was a new Centerline Wealth Advisors position in Q2 2026.
  • Eli Lilly made up 0.06% of Centerline Wealth Advisors's portfolio in Q2 2026, its #79 holding.
  • Centerline Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Centerline Wealth Advisors's Eli Lilly position peaked at $759K in Q1 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Centerline Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.